These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34535498)

  • 1. Retinoblastoma with significant intravitreal haemorrhage: a rare presentation.
    Chaudhary R; Tiwari T; Sharma R; Goyal S
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34535498
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.
    Kaczmarek JV; Bogan CM; Pierce JM; Tao YK; Chen SC; Liu Q; Liu X; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Friedman DL; Richmond A; Daniels AB
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):8. PubMed ID: 34757417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
    Xue K; Ren H; Meng F; Zhang R; Qian J
    BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity to intravitreal melphalan in a patient with retinoblastoma.
    Solaz-Ruiz MG; Pérez LA; Cauto-Picazo C; Barranco-González H; Pascual-Camps I; España-Gregori E
    Rom J Ophthalmol; 2023; 67(3):305-308. PubMed ID: 37876503
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravitreal injections of melphalan in the treatment of retinoblastoma vitreous seeding.
    Cieślik K; Rogowska A; Danowska M; Hautz W
    Adv Clin Exp Med; 2024 Feb; 33(2):119-125. PubMed ID: 37260052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOXICITY AND EFFICACY OF INTRAVITREAL MELPHALAN FOR RETINOBLASTOMA: 25 µg Versus 30 µg.
    Liao A; Hsieh T; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
    Retina; 2021 Jan; 41(1):208-212. PubMed ID: 32106160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
    Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
    Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K; Ren H; Zhang R; Yuan YF; Qian J
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F; Amoli FA
    Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E
    Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400
    [No Abstract]   [Full Text] [Related]  

  • 16. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH; Marr BP; Brodie SE; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2014 Aug; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.